BHPI
CAS No. 56632-39-4
BHPI ( BHPI; )
产品货号. M15059 CAS No. 56632-39-4
BHPI is a potent, noncompetitive small molecule ERα inhibitor.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
50MG | ¥6116 | 有现货 |
|
100MG | ¥10044 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称BHPI
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述BHPI is a potent, noncompetitive small molecule ERα inhibitor.
-
产品描述BHPI is a potent, noncompetitive small molecule ERα inhibitor (biomodulator) that selectively blocks proliferation of drug-resistant ERα-positive breast and ovarian cancer cells; distorts this normal action of E2–ERα and induces a massive and sustained ERα-dependent activation of the unfolded protein response (UPR), persistent inhibition of protein synthesis, converting UPR activation from cytoprotective to cytotoxic; completely blocked proliferation of ERα+ cancer cells at 100-1000 nM, induces tumor regression in mouse xenograft of MCF-7 cells.
-
同义词BHPI;
-
通路Endocrinology/Hormones
-
靶点Estrogen Receptor/ERR
-
受体Estrogen Receptor/ERR
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number56632-39-4
-
分子量331.36
-
分子式C21H17NO3
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥150 mg/mL
-
SMILESO=C1NC2=C(C=CC=C2C)C1(C3=CC=C(O)C=C3)C4=CC=C(O)C=C4
-
化学全称2H-Indol-2-one, 1,3-dihydro-3,3-bis(4-hydroxyphenyl)-7-methyl-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Andruska ND, et al. Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4737-42.
2. Zheng X, et al. Oncotarget. 2016 Jul 24;9(19):14741-14753.
3. Mao C, et al. Sci Rep. 2016 Oct 7;6:34753.
2. Zheng X, et al. Oncotarget. 2016 Jul 24;9(19):14741-14753.
3. Mao C, et al. Sci Rep. 2016 Oct 7;6:34753.
产品手册
关联产品
-
Giredestrant
Giredestrant potently competes with estradiol for binding and induces a conformational change within the ER ligand binding domain.?Giredestrant has anti-tumor activity.
-
Norethynodrel
A synthetic progestational hormone with actions and uses similar to those of progesterone.
-
Ospemifene
Ospemifene is a non-hormonal selective estrogen receptor modulator (SERM), used for the treatment of dyspareunia.